advisorsecurities master

DSGNDesign Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
14409
Ticker
DSGN
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-03-26
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
DSGN

Detail

Enriched 2026-08-14 20:47

Market cap
$917,447,003.66
Shares outstanding (class)
62,581,651
Shares outstanding (weighted)
62,581,651
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
55
Location
CARLSBAD, CA
Description

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data